Claire M. Coeshott, PhD Ask a Question Refer Patient Claire M. Coeshott, PhD, serves as the Director of the Immunology Laboratory for National Jewish Health Advanced Diagnostic Laboratories. Director, Immunology Laboratory Advanced Diagnostic Laboratories 5280 Top Doctors 2021 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Programs & Services Diagnostic Laboratories Education Education 1978 - 1982 University of Bristol, Bristol, UK, PhD, Immunology 1975 - 1978 University of Bristol, Bristol, UK, BSc Cell Pathology Publications Coeshott, C., Vang, B., Jones, M., and Nankervis, B. Large-scale Expansion and Characterization of CD3+ T-cells in the Quantum Cell Expansion System. J Transl Med. 2019 Aug 7;17(1):258. Cohn, A., Morse, M.A., O'Neil, B., Whiting, S., Coeshott, C., Ferraro, J., Bellgrau, D., Apelian, D. and Rodell, T.C. Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients with Solid Tumors Bearing Ras Mutations: Results from a Phase 1 Trial. J. Immunotherapy 41: 141-150, 2018. Gaggar, A., Coeshott, C., Apelian, D., Rodell, T., Shen, G., Subramanian, G. M. and McHutchinson, J.G. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study. Vaccine 32: 4925-4931, 2014. Stubbs, A.C., Martin, K.S., Coeshott, C., Skaates, S.V., Kuritzkes, D.R., Bellgrau, D., Franzusoff, A., Duke, R.C. and Wilson, C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nature Medicine 7:625-629, 2001. Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S.E., Wieczorek, M. Kroona, H., Leimer, A. and Cheronis, J. Converting enzyme-independent release of TNFα and IL-1β from stimulated THP-1, a human monocytic cell line, in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. USA, 96: 6261-6266, 1999. Conflicts of Interest National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations. Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 303.270.2766 Email: email@example.com Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.